RxDoctor Payments Data

Lauren Plyler

Acute Care · Memphis, TNNPI 1598137606

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.6% of the total across 368 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 26.9% of the total. Among acute care clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,178in general payments, 2019–2025

Across 368 payments — averaging $19.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Sanofi$709
  • Johnson & Johnson$633
  • Incyte Corporation$404
  • Pfizer$375
  • LEO Pharma Inc.$371
  • plus $3K from 22 others

What the payments were for

  • Food & beverage$6,86496%
  • Education$3134%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,178 in reported general payments places this provider in the 90th percentile of 738 acute care providers in Tennessee.

See all acute care providers in Tennessee

Medicare billing

Part B allowed, 2024
$146,494
Medicare patients
806
Services billed
3,051

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate76$2,849
Ketoconazole242$2,835
Fluocinonide48$1,903
Fluorouracil28$1,800
Metronidazole39$1,588
Doxycycline Hyclate107$1,405
Ciclopirox41$1,158
Fluocinolone Acetonide20$1,112
Nystatin58$1,084
Triamcinolone Acetonide90$1,014
Clindamycin Phosphate28$1,009
Betamethasone Dipropionate15$923
Dutasteride14$816
NystopNystatin12$277
Mupirocin30$274

Paid to pharmacies, not to this prescriber.

Other acute care in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →